EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ATR senses stiff extracellular matrix to promote epithelial-to-mesenchymal transition and immune suppression

Xinyi Tu, Xiangyu Zeng, Yaoliang Sun, Yaobin Ouyang, Lingling Zhu, Ping Yin, Kevin Pavelko, Roberto Leon-Ferre, Yanxia Jiang, Haidong Dong, Jodi Carter, Shouhai Zhu und 8 weitere

Journal of Clinical Investigation · 17.08.2026 · 136 (16)

DOI: 10.1172/jci192285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 07.07.2026. Verfasst von Xinyi Tu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Ataxia Telangiectasia Mutated Proteins, Extracellular Matrix, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NCI NIH HHS, Mayo Clinic Research Pipeline K2R Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our research uncovers a role for ATR in responding to ECM stiffness and promoting epithelial-to-mesenchymal transition (EMT) and metastasis. ATR, when deubiquitinated and upregulated by USP21 under enhanced ECM stiffness conditions, phosphorylates the nuclear protein SUN2, which promotes β-catenin nuclear translocation and EMT. ATM-mediated EMT promotes polymorphonuclear myeloid-derived suppressor cell recruitment and inhibits CD103 + dendritic cells, fostering an immunosuppressive tumor milieu. ATR inhibition disrupts this malignant cascade by promoting mesenchymal-to-epithelial transition to enhance antitumor immunity and mitigate metastases. Consistently, circulating HLA-DR + dendritic cells were also enhanced following treatment with the ATR inhibitor berzosertib in patients with therapeutically resistant early-stage breast cancer. Our data suggest that ATR-targeted therapy may be optimized by considering both DNA damage–dependent and EMT-inducing effects of ATR ATR promotes metastasis and immunosuppression through EMT process

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionAtaxia Telangiectasia Mutated ProteinsExtracellular MatrixBreast NeoplasmsNeoplasm ProteinsHumansFemaleAnimalsDendritic CellsMice

Stichwörter der Autor:innen

Breast cancerCell biologyCellular immune responseExtracellular matrixImmunologyOncology

Substanzen

Ataxia Telangiectasia Mutated ProteinsATR protein, humanNeoplasm Proteins

Autor:innen und Institutionen

  • Department of Radiation Oncology.
  • Molecular Pharmacology and Experimental Therapeutics.
  • Department of Immunology.
  • Department of Oncology.
  • Department of Medical Oncology, and.
  • Department of Urology, Mayo Clinic, Rochester, Minnesota, USA.

Förderung

  • NICHD NIH HHS
  • NCI NIH HHS
  • Mayo Clinic Research Pipeline K2R Award
  • National Cancer Center
  • Mayo Clinic Breast Caner SPORE pilot project
  • Eagle fellowship award
  • Wallace and Evelyn Simmers Career Development Award
  • Breast SPORE

Zitieren

APA

Tu, X., Zeng, X., Sun, Y., Ouyang, Y., Zhu, L., Yin, P., Pavelko, K., Leon-Ferre, R., Jiang, Y., Dong, H., Carter, J., Zhu, S., Sarkaria, J. N., Wang, L., Huang, J., Luo, K., Han, Y., Wu, Z., Lou, Z., & Mutter, R. W. (2026). ATR senses stiff extracellular matrix to promote epithelial-to-mesenchymal transition and immune suppression. Journal of Clinical Investigation, 136(16). https://doi.org/10.1172/jci192285

Vancouver

Tu X, Zeng X, Sun Y, Ouyang Y, Zhu L, Yin P, et al. ATR senses stiff extracellular matrix to promote epithelial-to-mesenchymal transition and immune suppression. Journal of Clinical Investigation. 2026;136(16). doi:10.1172/jci192285

BibTeX
@article{Tu2026,
  author = {Tu, Xinyi and Zeng, Xiangyu and Sun, Yaoliang and Ouyang, Yaobin and Zhu, Lingling and Yin, Ping and Pavelko, Kevin and Leon-Ferre, Roberto and Jiang, Yanxia and Dong, Haidong and Carter, Jodi and Zhu, Shouhai and Sarkaria, Jann N and Wang, Liewei and Huang, Jinzhou and Luo, Kuntian and Han, Yiqun and Wu, Zheming and Lou, Zhenkun and Mutter, Robert W},
  title = {ATR senses stiff extracellular matrix to promote epithelial-to-mesenchymal transition and immune suppression},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {16},
  doi = {10.1172/jci192285}
}
Kostenlos starten →